The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

Guinea celebrates today the elimination of sleeping sickness (also known as human African trypanosomiasis or HAT) as a public health problem.

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article.

"As a researcher dedicated to understanding how viral infections lead to chronic illness, I suspected from the beginning of the pandemic that SARS-CoV2 could trigger ME/CFS, so these results are ...

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

In addition to these proven drugs, the year saw the development of many new compounds ... significantly quicker resolution of the five typical symptoms of the Omicron SARS-CoV2 (Yamato et al., 2024).

It’s true to say that drug usage has a variety of negative consequences for its users and, on the whole, governments are right to advise against it. People in New York who smoke cannabis should ...

Weight-loss drugs like Ozempic may decrease your risk of developing 42 health conditions, but increase your chance of experiencing 19 others, according to one of the most comprehensive studies-of ...